The Owl

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. We design intelligent clinical technologies to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis, plaque build-up in the heart's arteries, not indirect markers such as risk factors and symptoms of the disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease diagnostics and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes. Cleerly empowers providers to go beyond traditional measures of heart disease by analyzing, characterizing, and quantifying types of plaque, so they can more accurately determine a patient's risk of heart attack and develop a treatment plan to improve heart health.

Greenspace Health is dedicated to transforming behavioral healthcare through innovative technology solutions that facilitate Measurement-Based Care (MBC). Their platform enables service providers to automate the collection of patient-reported outcome measures, offering intuitive dashboards that visualize symptom changes to inform clinical decisions and enhance therapeutic alliances. Organizations benefit from customized data insights, empowering them to assess service effectiveness, drive innovation, and ensure high-quality care. For health systems, Greenspace's solutions streamline care coordination, improve provider collaboration, and optimize resource allocation by identifying service gaps and reducing care costs. The platform supports clients and patients by allowing them to track their progress, fostering engagement, and promoting better clinical outcomes. Greenspace's commitment to privacy and security is evident through their SOC 2 Type II compliance.